ARCHIVES

Bevacizumab And Irinotecan May Increase Survival Of GBM

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

ASCO Picks Charles Balch To Succeed John Durant as Executive Vice President.

January 7, 2000

Arzerra Given Accelerated Approval For Leukemia

October 30, 2009

NCI Health Disparities Center Describes “Think Tank” Projects For Policy Change.

April 27, 2001

Study: Partial Kidney Removal Leads to Greater Survival

March 29, 2013

NCI CTEP-Approved Trials For the Month of December

December 26, 2014

Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter

October 15, 1976